General Information of This Drug (ID: DMNMW9R)

Drug Name
Pramipexole   DMNMW9R
Synonyms
Mirapex; Pramipexol; Pramipexolum; SUD919CL2Y; Mirapex (TN); Mirapexin (TN); Pramipexole [USAN:INN]; SND-919; Sifrol(TN); U-98528E; Pramipexole (USAN/INN); (-)-Pramipexole; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; 111GE001; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; 2-amino-6-propylaminotetrahydrobenzothiazole
Therapeutic Class
Antiparkinson Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Fibromyalgia DISZJDS2 MG30.01 Withdrawn [1]
------------------------------------------------------------------------------------
2 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Restless legs syndrome DISNWY00 7A80 Discontinued in Phase 3 [2]
Parkinson disease DISQVHKL 8A00.0 Discontinued in Phase 3 [3]
------------------------------------------------------------------------------------

References

1 Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate
2 Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients
3 Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients